Janux Therapeutics, Inc. (JANX)
14.81
-0.33
(-2.18%)
USD |
NASDAQ |
Jan 23, 16:00
14.69
-0.12
(-0.81%)
After-Hours: 20:00
Janux Therapeutics Research and Development Expense (TTM): 115.15M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.719B |
| Eli Lilly & Co. | 12.56B |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| MannKind Corp. | 49.90M |
| Madrigal Pharmaceuticals, Inc. | 296.43M |